Literature DB >> 26085847

Cumulative Hazard Ratio Estimation for Treatment Regimes in Sequentially Randomized Clinical Trials.

Xinyu Tang1, Abdus S Wahed2.   

Abstract

The proportional hazards model is widely used in survival analysis to allow adjustment for baseline covariates. The proportional hazard assumption may not be valid for treatment regimes that depend on intermediate responses to prior treatments received, and it is not clear how such a model can be adapted to clinical trials employing more than one randomization. Besides, since treatment is modified post-baseline, the hazards are unlikely to be proportional across treatment regimes. Although Lokhnygina and Helterbrand (Biometrics 63: 422-428, 2007) introduced the Cox regression method for two-stage randomization designs, their method can only be applied to test the equality of two treatment regimes that share the same maintenance therapy. Moreover, their method does not allow auxiliary variables to be included in the model nor does it account for treatment effects that are not constant over time. In this article, we propose a model that assumes proportionality across covariates within each treatment regime but not across treatment regimes. Comparisons among treatment regimes are performed by testing the log ratio of the estimated cumulative hazards. The ratio of the cumulative hazard across treatment regimes is estimated using a weighted Breslow-type statistic. A simulation study was conducted to evaluate the performance of the estimators and proposed tests.

Entities:  

Keywords:  Cumulative treatment effect; Non-proportional hazards; Sequentially randomized clinical trial; Stratified proportional hazards model

Year:  2015        PMID: 26085847      PMCID: PMC4467029          DOI: 10.1007/s12561-013-9089-6

Source DB:  PubMed          Journal:  Stat Biosci        ISSN: 1867-1764


  8 in total

1.  Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials.

Authors:  Jared K Lunceford; Marie Davidian; Anastasios A Tsiatis
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials.

Authors:  Abdus S Wahed; Anastasios A Tsiatis
Journal:  Biometrics       Date:  2004-03       Impact factor: 2.571

3.  Weighted Kaplan-Meier estimators for two-stage treatment regimes.

Authors:  Sachiko Miyahara; Abdus S Wahed
Journal:  Stat Med       Date:  2010-11-10       Impact factor: 2.373

Review 4.  Comparison of dynamic treatment regimes via inverse probability weighting.

Authors:  Miguel A Hernán; Emilie Lanoy; Dominique Costagliola; James M Robins
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-03       Impact factor: 4.080

5.  Estimating cumulative treatment effects in the presence of nonproportional hazards.

Authors:  Guanghui Wei; Douglas E Schaubel
Journal:  Biometrics       Date:  2007-12-05       Impact factor: 2.571

6.  Q-LEARNING WITH CENSORED DATA.

Authors:  Yair Goldberg; Michael R Kosorok
Journal:  Ann Stat       Date:  2012-02-01       Impact factor: 4.028

7.  Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.

Authors:  Katherine K Matthay; C Patrick Reynolds; Robert C Seeger; Hiroyuki Shimada; E Stanton Adkins; Daphne Haas-Kogan; Robert B Gerbing; Wendy B London; Judith G Villablanca
Journal:  J Clin Oncol       Date:  2009-01-26       Impact factor: 44.544

8.  Cox regression methods for two-stage randomization designs.

Authors:  Yuliya Lokhnygina; Jeffrey D Helterbrand
Journal:  Biometrics       Date:  2007-04-09       Impact factor: 2.571

  8 in total
  2 in total

1.  A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients.

Authors:  Erica E M Moodie; David A Stephens; Shomoita Alam; Mei-Jie Zhang; Brent Logan; Mukta Arora; Stephen Spellman; Elizabeth F Krakow
Journal:  Biom J       Date:  2018-05-16       Impact factor: 2.207

2.  Semiparametric Contrasts of Cumulative Pre-Treatment Mortality in the Presence of Dependent Censoring.

Authors:  Qi Gong; Douglas E Schaubel
Journal:  Stat Biosci       Date:  2014-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.